2 completed, 1 not yet recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Vascular Calcification: new trials by email Literature Review of Vascular Calcification trials Research Report on Vascular Calcification
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pentoxifylline for Vascular Calcification in Kidney Disease Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification | Phase 1 / Phase 2 | Not yet recruiting | Mansoura University | 80 | 2025-04-15 | 2025-04-01 |
| SEAPORT 1: Study of INZ-701 in Adults With Hemodialysis-Dependent End-Stage Kidney Disease INZ-701 - Calciphylaxis | Phase 1 | Completed | Inozyme Pharma | 11 | 2024-02-12 | 2026-08-24 |
| Arterial Imaging of Inflammation and Resolution After Endovascular Surgery 18F-FDG - Peripheral Arterial Disease, Claudication, Intermittent | Phase 1 | Completed | University of California, San Francisco | 9 | 2017-06-01 | 2020-11-30 |
Kidney Failure, Chronic (2) · Renal Insufficiency, Chronic (2) · Arterial Occlusive Diseases (1) · Calcinosis (1) · Calcinosis Cutis (1) · Calciphylaxis (1) · Calcium Metabolism Disorders (1) · Intermittent Claudication (1) · Peripheral Arterial Disease (1)
Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Calcinosis (2) · Calcium Metabolism Disorders (2) · Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Fluorodeoxyglucose F18 (1) · Pentoxifylline (1) · Tablets (1)
Inozyme Pharma (1) · Mansoura University (1) · University of California, San Francisco (1)
United States (2)
Michael S Conte, M.D. (1) · Miguel H Pampaloni, M.D., PhD. (1)